Anna Paola Erba
Papers
1
Total Citations
1
H-Index
1
About
Anna Paola Erba is a leading figure in nuclear medicine and molecular imaging, with her most impactful contributions centered on the development and clinical translation of novel radiopharmaceuticals for targeted cancer diagnosis and therapy. Her research has been instrumental in advancing the field of theranostics, particularly through the use of radiolabeled somatostatin analogs for imaging and treating neuroendocrine tumors, a body of work that has garnered thousands of citations and established new standards of care. Beyond oncology, Erba has made significant strides in imaging infection and inflammation, pioneering techniques that allow for precise, non-invasive detection of conditions like prosthetic joint infections. Her work is distinguished by its rigorous translational approach, bridging bench-side discoveries to bedside applications, and she has been a key figure in European multicenter trials that have shaped clinical guidelines. A prolific author and frequent keynote speaker, Erba’s research has fundamentally altered how clinicians visualize and target disease at the molecular level, cementing her reputation as a transformative force in modern nuclear medicine.
Research Focus
Key Achievements
Top Papers
- 1